Works by Hu, Shangying


Results: 23
    1
    2
    3
    4

    Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial.

    Published in:
    2021
    By:
    • Sierra, Mónica S;
    • Tsang, Sabrina H;
    • Hu, Shangying;
    • Porras, Carolina;
    • Herrero, Rolando;
    • Kreimer, Aimée R;
    • Schussler, John;
    • Boland, Joseph;
    • Wagner, Sarah;
    • Cortes, Bernal;
    • Rodríguez, Ana C;
    • Quint, Wim;
    • Doorn, Leen-Jan van;
    • Schiffman, Mark;
    • Sampson, Joshua N;
    • Hildesheim, Allan;
    • Group, Costa Rica Human Papillomavirus Vaccine Trial (CVT);
    • van Doorn, Leen-Jan;
    • Costa Rica Human Papillomavirus Vaccine Trial (CVT) Group
    Publication type:
    journal article
    5
    6

    The variations in the natural history of high‐risk human papillomavirus infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort study.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 5, p. 1043, doi. 10.1002/ijc.35290
    By:
    • Chen, Qi;
    • Yao, Xingmei;
    • Quan, Jiali;
    • Jia, Xinhua;
    • Li, Yufei;
    • Zhu, Kongxin;
    • Hu, Xiaowen;
    • Huang, Xingcheng;
    • Zhong, Guohua;
    • Qiu, Lingxian;
    • Bi, Zhaofeng;
    • Liao, Mengjun;
    • Chen, Lu;
    • Kuang, Xuefeng;
    • Wang, Zhe;
    • Hu, Shangying;
    • Zhuang, Chunlan;
    • Huang, Shoujie;
    • Wei, Lihui;
    • Chen, Wen
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 4, p. 458, doi. 10.1111/ajco.13833
    By:
    • Zhao, Fanghui;
    • Jastorff, Archana;
    • Hong, Ying;
    • Hu, Shangying;
    • Chen, Wen;
    • Xu, Xiaoqian;
    • Zhu, Yejiang;
    • Zhu, Jiahong;
    • Zhang, Xun;
    • Zhang, Wenhua;
    • Xu, Dacheng;
    • Wang, Dali;
    • Tang, Rong;
    • Sun, Yonghong;
    • Shen, Yiping;
    • Pan, Qinjing;
    • Yin, Jian;
    • Liu, Daokuan;
    • Liu, Bin;
    • Karkada, Naveen
    Publication type:
    Article
    15
    16
    17
    18

    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.

    Published in:
    Human Vaccines & Immunotherapeutics, 2021, v. 17, n. 4, p. 955, doi. 10.1080/21645515.2020.1829411
    By:
    • Hu, Shangying;
    • Xu, Xiaoqian;
    • Zhu, Fengcai;
    • Hong, Ying;
    • Hu, Yuemei;
    • Zhang, Xun;
    • Pan, Qinjing;
    • Zhang, Wenhua;
    • Zhang, Chengfu;
    • Yang, Xiaoping;
    • Yu, Jiaxi;
    • Zhu, Jiahong;
    • Zhu, Yejiang;
    • Chen, Feng;
    • Zhao, Shuang;
    • Karkada, Naveen;
    • Tang, Haiwen;
    • Bi, Dan;
    • Struyf, Frank;
    • Zhao, Fanghui
    Publication type:
    Article
    19
    20
    21
    22
    23